Works matching IS 01926233 AND DT 1999 AND VI 27 AND IP 1
Results: 26
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 78, doi. 10.1177/019262339902700115
- By:
- Publication type:
- Article
The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men".
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 123, doi. 10.1177/019262339902700124
- By:
- Publication type:
- Article
Correlation of Toxicity and Pharmacokinetic Properties of a Phosphorothioate Oligonucleotide Designed to Inhibit ICAM-1.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 95, doi. 10.1177/019262339902700117
- By:
- Publication type:
- Article
BR96 sFv-PE40 Immunotoxin: Nonclinical Safety Assessment.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 87, doi. 10.1177/019262339902700116
- By:
- Publication type:
- Article
Preclinical Development of Agents for the Treatment of Osteoporosis.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 143, doi. 10.1177/019262339902700126
- By:
- Publication type:
- Article
Animal Models of Arthritis: Relevance to Human Disease.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 134, doi. 10.1177/019262339902700125
- By:
- Publication type:
- Article
Tumor Models: Assessing Toxicity in Efficacy Studies.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 121, doi. 10.1177/019262339902700123
- By:
- Publication type:
- Article
Mechanisms of Disease and Injury: Utilization of Mutants, Monoclonals, and Molecular Methods.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 115, doi. 10.1177/019262339902700122
- By:
- Publication type:
- Article
Utilization of Genetically Altered Animals in the Pharmaceutical Industry.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 111, doi. 10.1177/019262339902700121
- By:
- Publication type:
- Article
Revolution through Genomics in Investigative and Discovery Toxicology.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 107, doi. 10.1177/019262339902700120
- By:
- Publication type:
- Article
Safety Evaluation of Human Living Skin Equivalents.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 101, doi. 10.1177/019262339902700118
- By:
- Publication type:
- Article
The Pathologist and Toxicologist in Pharmaceutical Product Discovery.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 104, doi. 10.1177/019262339902700119
- By:
- Publication type:
- Article
Development of a Recombinant Growth Factor and Fusion Protein: Lessons from GM-CSF.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 72, doi. 10.1177/019262339902700114
- By:
- Publication type:
- Article
The Toxicology of Interleukin-12: A Review.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 58, doi. 10.1177/019262339902700112
- By:
- Publication type:
- Article
Toxicologic Pathology of Cytokines, Cytokine Receptors, and Other Recombinant Human Proteins.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 53, doi. 10.1177/019262339902700111
- By:
- Publication type:
- Article
Preclinical and Early Clinical Development of Keratinocyte Growth Factor, an Epithelial- Specific Tissue Growth Factor.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 64, doi. 10.1177/019262339902700113
- By:
- Publication type:
- Article
Molecular Pathology in the Preclinical Development of Biopharmaceuticals.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 48, doi. 10.1177/019262339902700110
- By:
- Publication type:
- Article
Lesions and Identification of Crystalline Precipitates of Glycoprotein IIb-IIIa Antagonists in the Rat Kidney.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 38, doi. 10.1177/019262339902700108
- By:
- Publication type:
- Article
Use of In Vivo Confocal Microscopy to Understand the Pathology of Accidental Ocular Irritation.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 44, doi. 10.1177/019262339902700109
- By:
- Publication type:
- Article
Flow Cytometry in the Preclinical Development of Biopharmaceuticals.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 32, doi. 10.1177/019262339902700107
- By:
- Publication type:
- Article
Safety Assessment of Biotechnology-Derived Pharmaceuticals: ICH and Beyond.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 27, doi. 10.1177/019262339902700106
- By:
- Publication type:
- Article
Regulatory Decision Strategy for Entry of a Novel Biologic Therapeutic with a Clinically Unmonitorable Toxicity into Clinical Trials: Pre-IND Meetings and a Case Example.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 22, doi. 10.1177/019262339902700105
- By:
- Publication type:
- Article
Efficacy and Concentration-Response of Murine Anti-VEGF Monoclonal Antibody in Tumor-Bearing Mice and Extrapolation to Humans.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 14, doi. 10.1177/019262339902700104
- By:
- Publication type:
- Article
Synthetic Oligonucleotides: The Development of Antisense Therapeutics.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 8, doi. 10.1177/019262339902700103
- By:
- Publication type:
- Article
Preclinical Development Strategies for Novel Gene Therapeutic Products.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 4, doi. 10.1177/019262339902700102
- By:
- Publication type:
- Article
Pharmacology and Safety Assessment of Humanized Monoclonal Antibodies for Therapeutic Use.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 1, doi. 10.1177/019262339902700101
- By:
- Publication type:
- Article